Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688321'
s Days Payable Range Over the Past 10 Years
Min: 7.29 Med: 26.67 Max: 139.6
Current: 11.55
During the past 10 years, Shenzhen Chipscreen Biosciences Co's highest Days Payable was 139.60. The lowest was 7.29. And the median was 26.67.
SHSE:688321's Days Payable is ranked worse than 98.59% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:688321: 11.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Chipscreen Biosciences Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Days Payable falls into.
Shenzhen Chipscreen Biosciences Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Days Payable of 11.64 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. This is 56% below median its historical median of 26.67. Over the past decade, Shenzhen Chipscreen Biosciences Co's Days Payable has ranged from 7.29 to 139.60. According to the industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #912 out of 925 companies in the Drug Manufacturers industry, placing it in the top 98.6%.
Is Shenzhen Chipscreen Biosciences Co's Days Payable too high?
Shenzhen Chipscreen Biosciences Co's current Days Payable of 11.64 is 56% below median its 10-year median of 26.67. Over the past 10 years, this metric has ranged from a low of 7.29 to a high of 139.60. The Drug Manufacturers industry median Days Payable is 90.38. Shenzhen Chipscreen Biosciences Co's value of 11.64 is 87.1% below this industry median. Based on the distribution chart, Shenzhen Chipscreen Biosciences Co ranks #912 out of 925 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #912 out of 925 companies for Days Payable. This places Shenzhen Chipscreen Biosciences Co in the lower half of its industry. The industry median Days Payable is 90.38. Shenzhen Chipscreen Biosciences Co's value of 11.64 is 87.1% below this benchmark. Historically, Shenzhen Chipscreen Biosciences Co's own Days Payable has ranged from 7.29 to 139.60 over the past decade. While the company's 10-year median is 26.67 vs. the industry median of 90.38, Shenzhen Chipscreen Biosciences Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Chipscreen Biosciences Co's current Days Payable of 11.64 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Chipscreen Biosciences Co's current Days Payable is 11.64, which is 56% below median its own 10-year median of 26.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.16, compared to a current price of ¥28.79 — trading 24.6% below its estimated fair value. The current Days Payable is 11.64, which is 56% below median its 10-year median of 26.67 and 87.1% below the Drug Manufacturers industry median of 90.38. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Days Payable is 11.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued.
The current stock price of ¥28.79 is trading 24.6% below its estimated GF Value™ of ¥38.16.
GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Modestly Undervalued.
Key valuation signals for SHSE:688321:
Days Payable: 11.64 (56% below median its 10-year median of 26.67)
GF Value™: ¥38.16 vs. price of ¥28.79 (24.6% below fair value)
Industry Position: 87.1% below the Drug Manufacturers median (#912 of 925)
No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Chipscreen Biosciences Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688321 has been successfully added to your 
